Glaxosmithkline Pharmaceuticals Ltd. | GLAXO | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Revenue |
| 30,000 | 28,956 | 31,281 | 32,244 | 33,094 |
Cost of revenue |
| -13,977 | -12,655 | -13,580 | -13,079 | -13,127 |
Gross Profit |
| 16,022 | 16,301 | 17,701 | 19,165 | 19,967 |
Sales, general & ad... |
| -11,833 | -11,243 | -11,693 | -12,593 | -11,908 |
Depreciation |
| -263 | -380 | -486 | -827 | -793 |
Provision |
| 0 | 0 | 0 | 0 | 0 |
Other op inc/exp... |
| 0 | 0 | 0 | 0 | 0 |
Operating income |
| 3,926 | 4,678 | 5,522 | 5,746 | 7,266 |
Profit before tax |
| 5,112 | 5,400 | 6,827 | 3,058 | 5,505 |
Net Income |
| 3,368 | 3,507 | 4,454 | 932 | 3,581 |
| | | | | ||
EPS Basic |
| 19.88 | 20.70 | 26.29 | 5.50 | 21.14 |